Clinical Trial Detail

NCT ID NCT01970358
Title A Phase I Study With a Personalized NeoAntigen Cancer Vaccine in Melanoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

melanoma

Therapies

NeoVax melanoma vaccine

Age Groups: adult

No variant requirements are available.